0 0 0.00311401879838864 0.00311401879838864 0.00105705225266407 0.00468616975687789 -0.0264263063166014 -0.0189698025883497
Sign Up Today X
Thanks for submitting the form.
Stockreport

USPTO Allows Antibody Genus Claims in Patent Enabled by Integral Molecular's Paratope-PLUS™ CDR-Scanning [Yahoo! Finance]

Amgen Inc. (AMGN)  More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PHILADELPHIA April 21, 2026 /PRNewswire/ -- Integral Molecular, the industry leader in the discovery and engineering of antibodies against membrane proteins, announces that the United States Patent and Trademark Office (USPTO) has allowed a patent covering a genus of antibodies enabled using the company's Paratope-PLUS ® CDR-Scanning technology. The allowed claims protect a lead candidate and a family of structurally related antibodies binding the cancer target GPRC5D that share a common 'paratope' structural feature that is responsible for target binding. (PRNewsfoto/Integral Molecular Inc.) The issued patent demonstrates a new pathway for protecting antibody genera using structure-based claims supported by comprehensive experimental data, based on Integral Molecular's 2025 publication in Nature Biotechnology . The allowance comes in the wake of the 2023 U.S. Supreme Court ruling in Amgen Inc. v. Sanofi, which emphasized that genus claims must be supported by sufficient disclosu [Read more]
IMPACT SNAPSHOT EVENT TIME: AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AMGN alerts
from News Quantified
AMGN
NEWS
AMGN
Earnings
AMGN
Analyst Actions
AMGN
SEC Filings
Stockreport

USPTO Allows Antibody Genus Claims in Patent Enabled by Integral Molecular's Paratope-PLUS™ CDR-Scanning [Yahoo! Finance]

Amgen Inc.  (AMGN) 
More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PHILADELPHIA April 21, 2026 /PRNewswire/ -- Integral Molecular, the industry leader in the discovery and engineering of antibodies against membrane proteins, announces that the United States Patent and Trademark Office (USPTO) has allowed a patent covering a genus of antibodies enabled using the company's Paratope-PLUS ® CDR-Scanning technology. The allowed claims protect a lead candidate and a family of structurally related antibodies binding the cancer target GPRC5D that share a common 'paratope' structural feature that is responsible for target binding. (PRNewsfoto/Integral Molecular Inc.) The issued patent demonstrates a new pathway for protecting antibody genera using structure-based claims supported by comprehensive experimental data, based on Integral Molecular's 2025 publication in Nature Biotechnology . The allowance comes in the wake of the 2023 U.S. Supreme Court ruling in Amgen Inc. v. Sanofi, which emphasized that genus claims must be supported by sufficient disclosu [Read more]
IMPACT SNAPSHOT
EVENT TIME:
AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS